Showing results (2221-2230 of 2,338) with videos related to

Sort By:
Pageof 234
BMJ Open|September 5, 2019
Observational longitudinal multicentre investigation of acute pancreatitis (GOULASH PLUS): follow-up of the GOULASH study, protocolAlexandra Mikó, Bálint Erőss, Patrícia Sarlós, et al.
Annals of Clinical and Translational Neurology|July 29, 2024
The clinical relevance of MOG antibody testing in cerebrospinal fluidMolly Reynolds, Irene Tan, Kristy Nguyen, et al.
Molecular Psychiatry|October 15, 2021
A triple-network organization for the mouse brainFrancesca Mandino, Roël M Vrooman, Heidi E Foo, et al.
International Journal of Cancer|October 8, 2008
Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sampleClemens Schafmayer, Stephan Buch, Henry Völzke, et al.
Nature Communications|February 25, 2016
Rationally engineered Troponin C modulates in vivo cardiac function and performance in health and diseaseVikram Shettigar, Bo Zhang, Sean C Little, et al.
The American Journal of Gastroenterology|October 25, 2018
Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of CancerA R G Sheel, S Harrison, I Sarantitis, et al.
International Journal of Cancer|August 25, 2021
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)Lian Liu, Nicole Tonya Erickson, Ingrid Ricard, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 8, 2020
International Consensus Guidelines for Risk Factors in Chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic ClubPéter Hegyi, Andrea Párniczky, Markus M Lerch, et al.
Gastroenterology|June 7, 2021
Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma ModelsUjjwal M Mahajan, Qi Li, Ahmed Alnatsha, et al.
The Lancet. Oncology|August 31, 2016
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trialSebastian Stintzing, Dominik P Modest, Lisa Rossius, et al.
Pageof 234